Journal for ImmunoTherapy of Cancer (Jan 2022)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset

  • Enrico Maggi,
  • Giovanni Scambia,
  • Anna Fagotti,
  • Lorenzo Moretta,
  • Andrea Pelosi,
  • Irene Veneziani,
  • Valentina D'Oria,
  • Claudia Alicata,
  • Nadine Landolina,
  • Biancamaria Ricci

DOI
https://doi.org/10.1136/jitc-2021-003385
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

No abstracts available.